Clinical Trials

Jumo Health Appoints Brittany Erana CEO to Lead Next Phase of Growth

Jumo Health Appoints Brittany Erana CEO to Lead Next Phase of Growth

Erana joins the award-winning clinical trial solutions company to build patient-first solutions that accelerate study participation

Jumo Health, a global leader in optimizing the patient experience in clinical trials, today announced the appointment of Brittany Erana as Chief Executive Officer. With more than 20 years of experience in digitally enabled research and patient-centered innovation, Erana will lead the company’s next stage of strategic growth focused on increasing patient activation and reducing trial dropout rates.

Prior to joining Jumo Health, Erana served as General Manager of patient first digital solutions at PPD, one of the world’s leading contract research organizations. There, she oversaw digital transformation strategies that modernized clinical research operations, enhanced patient experience, and improved data collection.

“Building the future of healthcare with the patient at the center has been the throughline of my career,” said Erana. “I’m thrilled to be joining Jumo Health at this pivotal moment to help transform how people are engaged in clinical research from first touch to final visit, and improving how our clients bring new therapies to market for those who need them most.”

Erana will be responsible for guiding Jumo Health through a dynamic phase of growth and transformation in partnership with Falfurrias Management Partners, who acquired Jumo Health in August 2024. Her focus will be on expanding Jumo Health’s capabilities through organic and acquisitive growth opportunities, enabling the company to address key friction points in trial awareness, accessibility, and adherence, especially for underrepresented patient populations.

“As trial dropout rates rise, protocol complexity increases, and timelines lengthen, sponsors need more than study awareness campaigns; they need personalized, scalable patient experience solutions,” said Adam Cossman, Jumo Health’s Executive Chairman and an executive advisor on the Falfurrias team. “Brittany’s leadership will be pivotal in meeting this need and building upon Jumo Health’s legacy in clinical innovation.”

Explore AITechPark for the latest advancements in AI, IOT, Cybersecurity, AITech News, and insightful updates from industry experts!

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.

Related posts

IgniteData boosts clinical trial efficiency at top cancer center

PR Newswire

Lotus Clinical Research Announces Expanded Partnership with Veeva

PR Newswire

Risklick launches AI-based software for medical device clinical trials

PR Newswire